These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27431424)

  • 41. Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Rouse CE; Eckert LO; Babarinsa I; Fay E; Gupta M; Harrison MS; Kawai AT; Kharbanda EO; Kucuku M; Meller L; Mallett Moore T; Subelj M; Kochhar S; Tavares-Da-Silva F; ;
    Vaccine; 2017 Dec; 35(48 Pt A):6563-6574. PubMed ID: 29150062
    [No Abstract]   [Full Text] [Related]  

  • 42. Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Pellegrin S; Munoz FM; Padula M; Heath PT; Meller L; Top K; Wilmshurst J; Wiznitzer M; Das MK; Hahn CD; Kucuku M; Oleske J; Vinayan KP; Yozawitz E; Aneja S; Bhat N; Boylan G; Sesay S; Shrestha A; Soul JS; Tagbo B; Joshi J; Soe A; Maltezou HC; Gidudu J; Kochhar S; Pressler RM;
    Vaccine; 2019 Dec; 37(52):7596-7609. PubMed ID: 31783981
    [No Abstract]   [Full Text] [Related]  

  • 43. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Vergnano S; Buttery J; Cailes B; Chandrasekaran R; Chiappini E; Clark E; Cutland C; de Andrade SD; Esteves-Jaramillo A; Guinazu JR; Jones C; Kampmann B; King J; Kochhar S; Macdonald N; Mangili A; de Menezes Martins R; Velasco Muñoz C; Padula M; Muñoz FM; Oleske J; Sanicas M; Schlaudecker E; Spiegel H; Subelj M; Sukumaran L; Tagbo BN; Top KA; Tran D; Heath PT;
    Vaccine; 2016 Dec; 34(49):6038-6046. PubMed ID: 27491687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Beigel J; Kohl KS; Brinley F; Graham PL; Khuri-Bulos N; LaRussa PS; Nell P; Norton S; Stoltman G; Tebaa A; Warschaw K;
    Vaccine; 2007 Aug; 25(31):5745-53. PubMed ID: 17537552
    [No Abstract]   [Full Text] [Related]  

  • 45. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.
    Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I;
    Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484
    [No Abstract]   [Full Text] [Related]  

  • 46. Subcutaneous nodules: an important adverse event following immunization.
    Silcock R; Crawford NW; Perrett KP
    Expert Rev Vaccines; 2019 Apr; 18(4):405-410. PubMed ID: 30808246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).
    Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E
    Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysfunctional labor: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Boatin AA; Eckert LO; Boulvain M; Grotegut C; Fisher BM; King J; Berg M; Adanu RMK; Reddy U; Waugh JJS; Gupta M; Kochhar S; Kenyon S;
    Vaccine; 2017 Dec; 35(48 Pt A):6538-6545. PubMed ID: 29150059
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Serazin NA; Edem B; Williams SR; Ortiz JR; Kawade A; Das MK; Šubelj M; Edwards KM; Parida SK; Wartel TA; Munoz FM; Bastero P
    Vaccine; 2021 May; 39(22):3028-3036. PubMed ID: 33583673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse events following immunization: real causality and myths.
    Principi N; Esposito S
    Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Liu YC; Munoz FM; Izurieta HS; Tamborska AA; Solomon T; Law BJ; Chhabra N
    Vaccine; 2023 Mar; 41(11):1902-1910. PubMed ID: 36775774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reporting of vaccine safety data in publications: systematic review.
    Bonhoeffer J; Zumbrunn B; Heininger U
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):101-6. PubMed ID: 15386705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.
    Phuong LK; Bonetto C; Buttery J; Pernus YB; Chandler R; Goldenthal KL; Kucuku M; Monaco G; Pahud B; Shulman ST; Top KA; Ulloa-Gutierrez R; Varricchio F; de Ferranti S; Newburger JW; Dahdah N; Singh S; Bonhoeffer J; Burgner D;
    Vaccine; 2016 Dec; 34(51):6582-6596. PubMed ID: 27863715
    [No Abstract]   [Full Text] [Related]  

  • 54. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
    Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
    Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Terminological challenges in safety surveillance.
    Bate A; Brown EG; Goldman SA; Hauben M
    Drug Saf; 2012 Jan; 35(1):79-84. PubMed ID: 22136184
    [No Abstract]   [Full Text] [Related]  

  • 56. Collaborative improves monitoring of vaccine safety.
    Gearon CJ
    AHIP Cover; 2007; 48(5):16-8, 20, 22-4. PubMed ID: 17941571
    [No Abstract]   [Full Text] [Related]  

  • 57. Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Kachikis A; Eckert LO; Walker C; Oteng-Ntim E; Guggilla R; Gupta M; Patwardhan M; Mataya R; Mallett Moore T; Alguacil-Ramos AM; Keech C; Gravett M; Murphy H; Kochhar S; Chescheir N;
    Vaccine; 2017 Dec; 35(48 Pt A):6555-6562. PubMed ID: 29150061
    [No Abstract]   [Full Text] [Related]  

  • 58. Safety in numbers: anaphylaxis risk in childhood immunisation.
    Collinson A
    Arch Dis Child; 2012 Jun; 97(6):485-6. PubMed ID: 22611111
    [No Abstract]   [Full Text] [Related]  

  • 59. Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Gollamudi J; Sartain SE; Navaei AH; Aneja S; Kaur Dhawan P; Tran D; Joshi J; Gidudu J; Gollamudi J; Chiappini E; Varricchio F; Law B; Munoz FM
    Vaccine; 2022 Oct; 40(44):6431-6444. PubMed ID: 36150973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Cutland CL; Lackritz EM; Mallett-Moore T; Bardají A; Chandrasekaran R; Lahariya C; Nisar MI; Tapia MD; Pathirana J; Kochhar S; Muñoz FM;
    Vaccine; 2017 Dec; 35(48 Pt A):6492-6500. PubMed ID: 29150054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.